Wed, Aug 5, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Study shows endowments generate zero alpha, except from alternative investments

Wednesday, October 23, 2013

Matthias Knab, Opalesque:

A recent paper entitled Do (Some) University Endowments Earn Alpha? by academics Brad M. Barber from the University of California and Guojun Wang, a PhD student in the Department of Economics at the University of California asked do educational endowments earn superior returns?

The academics looked at the strong returns earned by some legendary endowments, such as Yale University under the management of David Swensen, which have led to the widespread adoption of the so-called endowment model of investing. Using NACUBO/Commonfund data from 1991 to 2011, they analysed the returns earned by U.S. educational endowments using simple style attribution models.

The authors first documented the returns on the average endowment match the returns of a 60% U.S. stock (S&P 500 Index) and 40% U.S. bond portfolio (Barclays Capital U.S. Aggregate Bond Index). When they restricted the attribution model to public stock (U.S. and international stock) and bond (U.S. bond) benchmarks, the average endowment earned an alpha close to zero, the public stock/bond benchmarks explained 99% of the time-series variation in the return of the average endowment, and the attribution model yielded sensible estimates of the typical stock and bond allocations (roughly 60% stock and 40% bonds).

They then focused on the returns earned by institutions, such as Ivy League and top-SAT schools, and top......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  2. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  3. Performance - Some hedge fund small-cap energy stocks have been free falling, Dan Loeb's simple strategy destroys the market, Baupost lost 1.4% last quarter as energy bargains proved elusive[more]

    Some hedge fund small-cap energy stocks have been free falling From Marketrealist.com: According to a July 28, 2015, Bloomberg article, there was a 34% fall in small-cap energy stocks over the past three months. These shares are tracked by the Russell 2000 Energy Index. Small-cap energy

  4. Legal - Hedge funds hit Rothstein Kass with $75m malpractice suit, JPMorgan questioned on private bank’s hedge fund disclosures, Kijani fund, seized by regulators in Cayman Islands, spotlights risks in lightly regulated market[more]

    Hedge funds hit Rothstein Kass with $75m malpractice suit From Law360.com: Two investment funds have sued Rothstein Kass & Co. PC for at least $75 million, claiming the New Jersey auditing firm committed accounting malpractice by failing to properly scrutinize overblown valuations of the

  5. Assets - Hedge funds are getting smoked by the commodities slump, Global ETF assets could more than double by 2020[more]

    Hedge funds are getting smoked by the commodities slump From Businessinsider.in: The collapse in commodity prices has burnt another hedge fund. Vermillion, a commodity hedge fund backed by Carlyle Group, has seen its flagship fund's assets fall from nearly $2 billion to less $50 million,

 

banner